Immediate versus Stage complete revascularization of high risk NSTE-ACS patients with multi vessel disease: Propensity Score Matching, Open-label, Non-inferiority RCT

Immediate versus Stage complete revascularization of high risk NSTE-ACS patients with multivessel disease: Propensity Score Matching, Open-label, Non-inferiority RCT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20241103002

Enrollment

117

Registered

2024-11-03

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immediate complete revascularization in high risk NSTE-ACS multi vessel disease is non-inferiority benefit to stage complete revascularization. complete revascularization, multivessel disease, NSTE-ACS, NSTEMI

Interventions

To complete revascularization of significant coronary artery disease by visualization, QCA or physiological studies, then they are scheduled to immediate PTCA with or without coronary stent implantati

Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

Immediate complete revascularization,Stage complete revascularization

Eligibility

Sex/Gender

All

Age

20 Years to 85 Years

Inclusion criteria

Inclusion criteria: high risk NSTE-ACS with multi vessel disease

Exclusion criteria

Exclusion criteria: CABG eligible

Design outcomes

Primary

Measure	Time frame
composite cardiovascular endpoints 24 months in-hospital and longterm mortality rate, fatal or non-fatal ACS, fatal or non-fatal stroke, target vessel revascularization (TVR), target lesion failure (TLF)	—

Secondary

Measure	Time frame
Safety 24 months BARC (Bleeding Academic Research Consortium (BARC) classifies bleeding into 5 types according to severity of bleeding between lowest type 1 through highest risk or serious bleeding of type 5.	—

Countries

Thailand

Contacts

Public ContactBhuritat Munagboon

Sawanpracharak Regional Hospital

bhuritatcardio@gmail.com0931437389

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026